Compounds for treating metabolic disorders

TW202629587APending Publication Date: 2026-07-16INNOVENT BIOLOGICS (SUZHOU) CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
INNOVENT BIOLOGICS (SUZHOU) CO LTD
Filing Date
2025-10-16
Publication Date
2026-07-16

Smart Images

  • Figure TWG2TA001068788_001
    Figure TWG2TA001068788_001
  • Figure TWG2TA001068788_002
    Figure TWG2TA001068788_002
  • Figure TWG2TA001068788_003
    Figure TWG2TA001068788_003
Patent Text Reader

Abstract

Disclosed herein are novel compounds for GIPR, GLP-1R and GCGR. Specifically, provided herein are GLP-1R / GIPR / GCGR triagonists peptides, and conjugates comprising an Fc fragment and GLP-1R / GIPR / GCGR triagonists peptides. Pharmaceutical compositions comprising these compounds, as disclosed herein, as well as uses thereof in treating metabolic conditions and disorders, such as diabetes mellitus, type
Need to check novelty before this filing date? Find Prior Art